BChE/MAO-B-IN-2
BChE/MAO-B-IN-2 is a dual inhibitor of BChE (IC50 = 0.05 μM, Ki = 0.01 μM) and MAO-B (IC50 = 0.45 μM, Ki = 0.08 μM) with good blood-brain barrier permeability. BChE/MAO-B-IN-2 exhibits antioxidant activity, including DPPH radical scavenging, CUPRAC copper ion reduction, and superoxide anion scavenging. BChE/MAO-B-IN-2 can be used for the study of Alzheimer's disease (AD).
For research use only. We do not sell to patients.
- Formula: C17H22N2O2
- Molecular Weight:286.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
MAO-B 0.45 μM (IC50) |
MAO-B 0.08 μM (Ki) |
hBCHE 0.05 μM (IC50) |
hBCHE 0.01 μM (IC50) |
MAO-A 5.00 μM (IC50) |
MAO-A 1.20 μM (Ki) |
AChE 0.8 μM (Ki) |
AChE 2 μM (EC50) |
In Vitro
BChE/MAO-B-IN-2 (Compound 4a-S) shows DPPH radical scavenging activity (IC50 = 3.57 mM), antioxidant activity in the CUPRAC assay (IC50 = 33 μM) and superoxide anion scavenging capacity (IC50 = 24 μM)[1].
MAO-B-IN-48 (1-25 μM) does not exhibit cytotoxic effects on HepG2 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:40mg/kg of AlCl3 was administered intraperitoneally (i.p.) to male Balb/c mice for 30 days[1]
-
Dosage:20 mg/kg
-
Administration:i.g. for 1 week
-
Result:Ameliorated the cognitive impairment induced by AlCl3 in mice.
Chemical Information
-
Molecular Weight 286.37
-
Formula C17H22N2O2
-
SMILES
C#CCN[C@H](C1=CC(OC(N2CCCCC2)=O)=CC=C1)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
[1]. Teke Tuncel S, et al. Multitarget-directed carbamate and carbamothioate derivatives: Cholinesterase and monoamine oxidase inhibition, anti-β-amyloid (Aβ) aggregation, antioxidant and blood-brain barrier permeation properties against Alzheimer's disease. Eur J Med Chem. 2025 Nov 15;298:117986. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)